Virginie Westeel
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Perioperative immune checkpoint inhibitors with or without chemotherapy versus placebo with or without chemotherapy in elderly people with localised non-small cell lung cancer.
Journal: The Cochrane database of systematic reviews
Published: July 13, 2026
Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.
Journal: Respiratory medicine and research
Published: May 19, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 03, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2026
Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 23, 2025
External validation of the CAPAD score to predict the occurrence of clinically significant pneumothorax after CT-guided percutaneous transthoracic lung biopsy.
Journal: Respiratory medicine and research
Published: December 09, 2025
Long-Term Response and Survival in Extensive-Stage SCLC Receiving Atezolizumab Plus Chemotherapy in a Real-World Setting: IFCT-1905 CLINATEZO.
Journal: JTO clinical and research reports
Published: November 14, 2025
Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 15, 2025
Detecting Airway Involvement in Non-Asthmatic Eosinophilic Disorders: Diagnostic Utility of Fractional Exhaled Nitric Oxide (FeNO).
Journal: Advances in respiratory medicine
Published: August 15, 2025
Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS".
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 11, 2025
Perioperative immunotherapy strategies for resectable non-small cell lung cancer.
Journal: The Cochrane database of systematic reviews
Published: May 19, 2025
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: May 06, 2025
Last Updated: 09/26/2026